Neuroscientific Biopharmaceuticals Ltd has released a press release.
Appointment of Interim CEO
Filed with ASX ·
6ix hasn’t read this filing yet.
Neuroscientific Biopharmaceuticals Ltd. on 6ix
In the deck
Story so far
Earlier from Neuroscientific Biopharmaceuticals
- Investor Update Presentation
- CEO Resignation
- HREC decision to not approve Phase I Clinical Trial
- 2022 Annual Report and Appendix 4E
- NeuroScientific releases FY2022 Results
Later from Neuroscientific Biopharmaceuticals
- NSB files new patent
- R&D Tax Incentive Refund Received
- Positive treatment effect in MS animal study
- 2023 Annual Report and Appendix 4E
- Appointment of CEO
Follow Neuroscientific Biopharmaceuticals into a list and get an email when it puts out news.
Follow Neuroscientific Biopharmaceuticals